Voluntary nationwide recall: Clonazepam (Endo – November)

Dec. 2024Pharmacy Updates

Endo USA Inc. has recalled certain lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV). This is an expansion of a previous recall by Endo. Clonazepam is used to treat panic disorder and certain seizures.

This product is being recalled because the cartons of some packs show the incorrect product strength. The blister strips inside the product pack show the correct strength.

Using this drug at a higher dose than prescribed may cause sleepiness, dizziness, loss of muscle control, and confusion.

To see if your medication was recalled, please contact your doctor or the pharmacy where you received it or visit the FDA website below. If you have an affected lot of Clonazepam, you should stop using the medicine and return it to the place where you got it or throw it away.

As of Nov. 18, there had been no reports of adverse events related to this recall.

To learn more about this recall:

  • Call Inmar Inc. at 1-855-589-1869. Help is available Monday through Friday from 9 a.m. to 5 p.m. EST.
  • Visit the FDA website.

Recent Announcements

Special notice: Important policy changes

Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.
May 2025Important Notices

Provider OnLine Enhancements

Provider OnLine will be launching enhancements to the authorization process on April 18, 2025. The enhancement will include the following updates:
Apr. 2025Important Notices

Fostering Trust in Vaccinations Through Shared Decision Making

Please join us for a live, CME-accredited webinar on Wednesday, June 4, from noon to 1 p.m. that will provide an overview of fostering trust in vaccinations through shared decision making.
Apr. 2025Education/Webinars